20 September 2022
New radiolabelling method for personalised cancer treatment
Researchers from TU Delft have found a new method to efficiently make nano carriers loaded with radioactive salts for both medical imaging and treatment. Because the assembly of these nano carriers is incredibly simple, the innovation is very suitable for clinical research and treatments of cancer patients.
27 June 2022
This physicist’s greenhouse-coatingincreases crop harvest
20 April 2022
Dutch Research Council Veni grant for Robin de Kruijff
The Dutch Research Council (NWO) has awarded a Veni grant to researcher Robin de Kruijff of the Reactor Institute Delft (RID) for her research on a new type of radionuclide generator which, among other things, can obviate the global bottleneck in cancer research. The new generator will, moreover, be the first recyclable one of its kind. “I hope that my new type of generator will ultimately make diagnostic treatments much more accessible and less dependent on a handful of reactors”, says De Kruijff.
17 March 2022
How fuels work in the next generation of reactors
Recently an important project on fuels for future generation of reactors has been concluded. The aim of the INSPYRE project: investigation of fast reactor Mixed Oxide (MOX) fuel to support the development and qualification of the fuels for the future generation of reactors.
10 March 2022
The Battolyser: battery and hydrogen factory in one
Currently, storage is the key issue holding back the energy transition. Professor Fokko Mulder and CEO Mattijs Slee from Battolyser Systems are within reach of the solution: the Battolyser is a battery and a hydrogen factory in one. The TU Delft spin-off is a textbook example of how to create impact from research.
24 January 2022
TU Delft's Reactor Institute takes another step forward as a testing ground for innovation
The Reactor Institute Delft (RID) continuously invests in better measuring methods and techniques in order to facilitate pioneering research. We have accelerated this with the OYSTER (Optimised Yield - for Science, Technology & Education - of Radiation) programme.
25 October 2021
TU Delft spin-off MILabs acquired by Rigaku Corporation
MILabs, a TU Delft spin-off that develops ground breaking imaging devices, is acquired by Rigaku Corporation. Founded in 2006, MILabs provides pre-clinical imaging systems and equipment with higher efficiency and accuracy than conventional alternatives. MILabs has developed a unique system that enables high performance nuclear medicine imaging. The innovative technique contributes to the quest for new therapies and new insights into disease biology in research labs around the world.